Cited by 1,817PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase SignalingMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 101 of the 103 references it cites were found in a registry or an index.

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

Open access

Mendoza, Michelle C., Er, E. Emrah, Blenis, John·2011·Trends in Biochemical Sciences

DOI 10.1016/j.tibs.2011.03.006PMC PMC3112285

Open this paper in CoChat — free account

Abstract

The Ras-extracellular signal-regulated kinase (Ras-ERK) and phosphatidylinositol 3-kinase-mammalian target of rapamycin (PI3K-mTOR) signaling pathways are the chief mechanisms for controlling cell survival, differentiation, proliferation, metabolism, and motility in response to extracellular cues. Components of these pathways were among the first to be discovered when scientists began cloning proto-oncogenes and purifying cellular kinase activities in the 1980s. Ras-ERK and PI3K-mTOR were originally modeled as linear signaling conduits activated by different stimuli, yet even early experiments hinted that they might intersect to regulate each other and co-regulate downstream functions. The extent of this cross-talk and its significance in cancer therapeutics are now becoming clear.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.tibs.2011.03.006

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,578
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,244
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
Cell Survival Promoted by the Ras-MAPK Signaling Pathway by Transcription-Dependent and -Independent Mechanisms
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,908
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Johannessen, C. M., Boehm, J. S., Kim, S. Y., Thomas, S. R., Wardwell, L., Johnson, L. A., Emery, C. M., Stransky, N., Cogdill, A. P., Barretina, J., et al. (2010) · Nature · doi:10.1038/nature09627 · Cited by 1,460

Flagged first, then by citations

Show all 103 references

2 of the 103 references couldn’t be matched to a known paper.

Sorted by citations

Items 501–600 of 1,004

Knowledge-Based Analysis for Detecting Key Signaling Events from Time-Series Phosphoproteomics Data
Yang, P., Zheng, X., Jayaswal, V., Hu, G., Yang, J. Y. H., & Jothi, R. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004403 · Cited by 42
Modeling Signaling Networks to Advance New Cancer Therapies
Sáez-Rodríguez, J., MacNamara, A., & Cook, S. J. (2015) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-104927 · Cited by 39
Apoptosis induced by Trimethyltin chloride in human neuroblastoma cells SY5Y is regulated by a balance and cross-talk between NF-κB and MAPKs signaling pathways
Yan, Q., Liang, Y., Du, Q., Fan, P., Xu, H., Xu, Y., & Shi, N. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1021-9 · Cited by 39
The Quest for Targets Executing MYC-Dependent Cell Transformation
Hartl, M. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00132 · Cited by 40
Direct binding of MEK1 and MEK2 to AKT induces Foxo1 phosphorylation, cellular migration and metastasis
Procaccia, S., Ordan, M., Cohen, I., Bendetz-Nezer, S., & Seger, R. (2017) · Scientific Reports · doi:10.1038/srep43078 · Cited by 40
Hedgehog pathway and smoothened inhibitors in cancer therapies
Chahal, K. K., Parle, M., & Abagyan, R. A. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000609 · Cited by 38
Targeting the intracellular signaling “STOP” and “GO” pathways for the treatment of alcohol use disorders
Dorit Ron, A., & Berger, A. L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4882-z · Cited by 37
Chromosomal Instability Induces Cellular Invasion in Epithelial Tissues
Benhra, N., Barrio, L., Muzzopappa, M., & Milán, M. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.08.021 · Cited by 39
Raman micro-spectroscopy monitors acquired resistance to targeted cancer therapy at the cellular level
Hammoud, M. K., Yosef, H. K., Lechtonen, T., Aljakouch, K., Schuler, M., Alsaidi, W., Daho, I., Maghnouj, A., Hahn, S. A., El‐Mashtoly, S. F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33682-7 · Cited by 42
Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors
Loganathan, S. N., Tang, N., Holler, A. E., Wang, N., & Wang, J. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-1151 · Cited by 39
Combination MEK and mTOR inhibitor therapy is active in models of glioblastoma
Schreck, K. C., Allen, A. N., Wang, J., & Pratilas, C. A. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa138 · Cited by 39
The kinase PDK1 regulates regulatory T cell survival via controlling redox homeostasis
Feng, P., Yang, Q., Luo, L., Sun, Y., Lv, W., Wan, S., Guan, Z., Xiao, Z., Liu, F., Li, Z., et al. (2021) · Theranostics · doi:10.7150/thno.63992 · Cited by 39
Loss of FBXO31-mediated degradation of DUSP6 dysregulates ERK and PI3K-AKT signaling and promotes prostate tumorigenesis
Duan, S., Moro, L., Qu, R., Simoneschi, D., Cho, H., Jiang, S., Zhao, H., Chang, Q., de Stanchina, E., Arbini, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109870 · Cited by 40
Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer
Kitai, H., Choi, P. H., Yang, Y. C., Boyer, J. A., Whaley, A., Pancholi, P., Thant, C., Reiter, J., Chen, K., Markov, V., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50063-z · Cited by 41
Targeting SHIP1 and SHIP2 in Cancer
Pedicone, C., Meyer, S. T., Chisholm, J. D., & Kerr, W. G. (2021) · Cancers · doi:10.3390/cancers13040890 · Cited by 42
Mechanosensitive Piezo1 Channel Evoked-Mechanical Signals in Atherosclerosis
Shinge, S. A. U., Zhang, D., Muluh, T. A., Nie, Y., & Yu, F. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s319789 · Cited by 40
IL-1β-activated PI3K/AKT and MEK/ERK pathways coordinately promote induction of partial epithelial–mesenchymal transition
Tabei, Y., & Nakajima, Y. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01775-8 · Cited by 37
The proinflammatory cytokine, interleukin-17A, augments mitochondrial function and neurite outgrowth of cultured adult sensory neurons derived from normal and diabetic rats
Habash, T., Saleh, A. J., Chowdhury, S. R., Smith, D. R., & Fernyhough, P. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.08.016 · Cited by 38
Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner
Roffé, M., Lupinacci, F. C. S., Soares, L. C., Hajj, G. N. M., & Martins, V. R. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.004 · Cited by 38
Metformin Synergistically Potentiates the Antitumor Effects of Imatinib in Colorectal Cancer Cells
Lee, J., Park, D., & Lee, Y. (2017) · Development & Reproduction · doi:10.12717/dr.2017.21.2.139 · Cited by 40
Soft tissue sarcomas: From a morphological to a molecular biological approach
Oda, Y., Yamamoto, H., Kohashi, K., Yamada, Y., Iura, K., Ishii, T., Maekawa, A., & Bekki, H. (2017) · Pathology International · doi:10.1111/pin.12565 · Cited by 38
Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms
Fu, L.-N., Yq, W., Tan, J., Xu, J., Gao, Q.-Y., Chen, Y., & Fang, J.-Y. (2017) · Oncogene · doi:10.1038/onc.2017.345 · Cited by 39
ERK Is a Critical Regulator of JC Polyomavirus Infection
DuShane, J. K., Wilczek, M. P., Mayberry, C. L., & Maginnis, M. S. (2018) · Journal of Virology · doi:10.1128/jvi.01529-17 · Cited by 38
Dysregulated long non-coding RNAs in the temporal lobe epilepsy mouse model
Jang, Y., Moon, J., Lee, S., Jun, J. S., Lim, J., Lim, J., Park, B.-S., Yu, J.-S., Park, D.-K., Yang, A. R., et al. (2018) · Seizure · doi:10.1016/j.seizure.2018.04.010 · Cited by 38
Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types
Vazhappilly, C. G., Saleh, E., Ramadan, W. S. H., Menon, V., Al-Azawi, A. M., Tarazi, H., Abdu-Allah, H. H. M., El‐Shorbagi, A., & El‐Awady, R. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0626-5 · Cited by 38
Chemoresistance and targeting of growth factors/cytokines signalling pathways: towards the development of effective therapeutic strategy for endometrial cancer.
Guo, F., Zhang, H., Jia, Z., Cui, M., & Tian, J. (2018) · Europe PMC (PubMed Central) · Cited by 38
Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer
Thomas, J. V., & Sonpavde, G. (2022) · Cancers · doi:10.3390/cancers14071795 · Cited by 41
Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via mTORC1 inhibition
Sun, D., Liu, H., Dai, X., Zheng, X., Yan, J., Wei, R., Fu, X., Huang, M., Shen, A., Huang, X., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.029 · Cited by 38
Whole transcriptome analysis of gestational trophoblastic neoplasms reveals altered PI3K signaling pathway in epithelioid trophoblastic tumor
Cho, E. J., Chun, S., Park, H., Sung, C. O., & Kim, K.-R. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.09.022 · Cited by 37
Survival strategies of cancer cells: the role of macropinocytosis in nutrient acquisition, metabolic reprogramming, and therapeutic targeting
Xu, G., Zhang, Q., Cheng, R., Qu, J., & Li, W. (2025) · Autophagy · doi:10.1080/15548627.2025.2452149 · Cited by 41
Apocynin and Diphenyleneiodonium Induce Oxidative Stress and Modulate PI3K/Akt and MAPK/Erk Activity in Mouse Embryonic Stem Cells
Kučera, J., Binó, L., Štefková, K., Jaroš, J., Vašíček, O., Večeřa, J., Kubala, L., & Pachernı́k, J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7409196 · Cited by 38
The progesterone-induced enhancement of object recognition memory consolidation involves activation of the extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin (mTOR) pathways in the dorsal hippocampus
Orr, P. T., Rubin, A. J., Fan, L., Kent, B. A., & Frick, K. M. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.01.004 · Cited by 41
ALA-PDT suppressing the cell growth and reducing the lipogenesis in human SZ95 sebocytes by mTOR signaling pathway in vitro
Tuo, J., Wang, Q., Zouboulis, C. C., Liu, Y., Ma, Y., Ma, L., Ying, J., Zhang, C., & Xiang, L. F. (2017) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2017.03.006 · Cited by 37
Exercise Amaliorates Metabolic Disturbances and Oxidative Stress in Diabetic Cardiomyopathy: Possible Underlying Mechanisms
Mahmoud, A. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4307-9_12 · Cited by 37
Uncoupling of ER/Mitochondrial Oxidative Stress in mTORC1 Hyperactivation-Associated Skin Hypopigmentation
Yang, F., Yang, L., Wataya‐Kaneda, M., Yoshimura, T., Tanemura, A., & Katayama, I. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.10.007 · Cited by 38
Phosphatidylinositol 3‐Kinase–DNA Methyltransferase 1–miR‐1281–Histone Deacetylase 4 Regulatory Axis Mediates Platelet‐Derived Growth Factor–Induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells
Li, Y., Li, L., Qian, Z., Lin, B., Chen, J., Luo, Y., Qu, J., Raj, J. U., & Gou, D. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007572 · Cited by 37
Zinc-mediated Neurotransmission in Alzheimer's Disease: A Potential Role of the GPR39 in Dementia
Rychlik, M., & Młyniec, K. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190704153807 · Cited by 37
Hypoxia-induced Downregulation of SRC-3 Suppresses Trophoblastic Invasion and Migration Through Inhibition of the AKT/mTOR Pathway: Implications for the Pathogenesis of Preeclampsia
He, C., Shan, N., Xu, P. A., Ge, H., Yuan, Y. J., Liu, Y., Zhang, P., Wen, L., Zhang, F., Xiong, L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46699-3 · Cited by 37
DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis
Barroso‐Chinea, P., Luis-Ravelo, D., Fumagallo-Reading, F., Castro‐Hernández, J., Salas-Hernández, J., Rodríguez-Núñez, J., Febles-Casquero, A., Cruz‐Muros, I., Afonso‐Oramas, D., Abreu-González, P., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1668606 · Cited by 37
Oncopreventive effects of theanine and theobromine on dimethylhydrazine-induced colon cancer model
Shojaei‐Zarghani, S., Khosroushahi, A. Y., & Rafraf, M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111140 · Cited by 37
mTOR pathway and DNA damage response: A therapeutic strategy in cancer therapy
Pazhooh, R. D., Farnood, P. R., Asemi, Z., Mirsafaei, L., Yousefi, B., & Mirzaei, H. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103142 · Cited by 36
Towards combinatorial targeted therapy in melanoma: From pre-clinical evidence to clinical application (Review)
Grazia, G., Penna, I., Perotti, V., Anichini, A., & Tassi, E. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2491 · Cited by 38
Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer
Bradford, L. S., Rauh-Hain, A., Clark, R. M., Groeneweg, J. W., Zhang, L., Borger, D. R., Zukerberg, L. R., Growdon, W. B., Foster, R., & Rueda, B. R. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.02.022 · Cited by 36
DEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K/AKT and by up-regulating p38 MAP kinase
Srinivas, K. P., Remadevi, V., Dan, V. M., Sajitha, I. S., Prakash, R., Rahul, P. V., Santhoshkumar, T. R., Lakshmi, S., & Pillai, M. R. (2016) · Oncotarget · doi:10.18632/oncotarget.8131 · Cited by 39
The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer
Park, K., Yang, H., Choi, J., Seo, S., Kim, D., Lee, C. H., Jeon, H., Kim, S., & Lee, D. H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.028 · Cited by 36
Glutamine Metabolism in Both the Oxidative and Reductive Directions Is Triggered in Shrimp Immune Cells (Hemocytes) at the WSSV Genome Replication Stage to Benefit Virus Replication
He, S.-T., Lee, D.-Y., Tung, C.-Y., Li, C.-Y., & Wang, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02102 · Cited by 37
Regulation of the error-prone DNA polymerase Polκ by oncogenic signaling and its contribution to drug resistance
Temprine, K., Campbell, N. R., Huang, T. H., Langdon, E. M., Simon-Vermot, T., Mehta, K., Clapp, A., Chipman, M. E., & White, R. M. (2020) · Science Signaling · doi:10.1126/scisignal.aau1453 · Cited by 40
Feedback, Crosstalk and Competition: Ingredients for Emergent Non-Linear Behaviour in the PI3K/mTOR Signalling Network
Ghomlaghi, M., Hart, A., Hoang, N., Shin, S., & Nguyen, L. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136944 · Cited by 39
Targeting RAS mutants in malignancies: successes, failures, and reasons for hope
Yang, H. S., Zhou, X., Fu, D., Le, C., Wang, J., Zhou, Q., Liu, X., Yuan, Y., Ding, K., & Xiao, Q. (2022) · 癌症：英文版 · doi:10.1002/cac2.12377 · Cited by 38
Bradykinin antagonists and thiazolidinone derivatives as new potential anti-cancer compounds
Avdieiev, S. S., Gera, L., Havrylyuk, D., Hodges, R. S., Lesyk, R., Ribrag, V., Vassetzky, Y. S., & Kavsan, V. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.06.046 · Cited by 36
Divergent Metabolic Regulation of Autophagy and mTORC1—Early Events in Alzheimer’s Disease?
Shafei, M. A., Harris, M., & Conway, M. E. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00173 · Cited by 38
Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis
Szukiewicz, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512195 · Cited by 39
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors
Baldelli, E., Bellezza, G., Haura, E. B., Crinò, L., Cress, W. D., Deng, J., Ludovini, V., Sidoni, A., Schabath, M. B., Puma, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5941 · Cited by 34
PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases
Ziv, E., Bergen, M., Yarmohammadi, H., Boas, F. E., Petre, E. N., Sofocleous, C. T., Yaeger, R. D., Solit, D. B., Solomon, S. B., & Erinjeri, J. P. (2017) · Oncotarget · doi:10.18632/oncotarget.15278 · Cited by 35
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3 spatially mediates autophagy through the AMPK signaling pathway
Yan, S., Wei, X., Xu, S., Sun, H., Wang, W., Liu, L., Jiang, X., Zhang, Y., & Che, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.20757 · Cited by 36
Characterization of the Molecular Mechanisms Underlying Glucose Stimulated Insulin Secretion from Isolated Pancreatic β-cells Using Post-translational Modification Specific Proteomics (PTMomics)
Kang, T., Jensen, P., Huang, H., Christensen, G. L., Billestrup, N., & Larsen, M. R. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000217 · Cited by 34
Rapamycin Modulates Glucocorticoid Receptor Function, Blocks Atrophogene REDD1, and Protects Skin from Steroid Atrophy
Lesovaya, E. A., Agarwal, S., Readhead, B., Vinokour, E. I., Baida, G. E., Bhalla, P., Игоревич, К. К., Геннадиевна, Я. М., Platanias, L. C., Dudley, J. T., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.02.045 · Cited by 35
CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling
Liu, Z., Mi, C., Xie, L., Liu, T., Zou, Z., Li, Y., Chen, P., Peng, X., Ma, C., Zhang, W., et al. (2018) · Aging · doi:10.18632/aging.101571 · Cited by 35
mTOR Inhibitors in Advanced Biliary Tract Cancers
Wu, C., Chen, M., & Yeh, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030500 · Cited by 35
Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells
Ye, R.-S., Pi, M., Nooh, M. M., Bahout, S. W., & Quarles, L. D. (2019) · Molecular Pharmacology · doi:10.1124/mol.118.115014 · Cited by 36
Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma
Peng, X., Liu, Y., Zhu, S., Peng, X., Li, H., Jiao, W., Lin, P., Zhang, Z., Qiu, Y., Jin, M., et al. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-03047-2 · Cited by 35
Type 2 diabetes – unmet need, unresolved pathogenesis, mTORC1-centric paradigm
Bar‐Tana, J. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09545-w · Cited by 38
Covalent Targeting of Ras G12C by Rationally Designed Peptidomimetics
Yoo, D. Y., Hauser, A. D., Joy, S. T., Bar‐Sagi, D., & Arora, P. S. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00204 · Cited by 35
Multifunctional Roles of the Actin-Binding Protein Flightless I in Inflammation, Cancer and Wound Healing
Strudwick, X. L., & Cowin, A. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603508 · Cited by 35
Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
Chandrasekaran, S., Funk, C. R., Kleber, T. J., Paulos, C. M., Shanmugam, M., & Waller, E. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718621 · Cited by 36
Forkhead Box O1 Regulates Macrophage Polarization Following Staphylococcus aureus Infection: Experimental Murine Data and Review of the Literature
Wang, Y.-C., Ma, H.-D., Yin, X.-Y., Wang, Y., Liu, Q.-Z., Yang, J.-B., Shi, Q.-H., Sun, B., Gershwin, M. E., & Lian, Z. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8531-1 · Cited by 34
The role of flavonoids in the regulation of epithelial‐mesenchymal transition in cancer: A review on targeting signaling pathways and metastasis
Proença, C., Freitas, M., Ribeiro, D., Rufino, A. T., Fernandes, E. G. R., & de Oliveira, J. M. P. F. (2023) · Medicinal Research Reviews · doi:10.1002/med.21966 · Cited by 37
Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway
Elbaset, M. A., Mohamed, B. M. S. A., Gad, S. A., Afifi, S. M., Esatbeyoglu, T., Abdelrahman, S. S. M., & Fayed, H. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-42210-1 · Cited by 37
Research Progress of Porcine Reproductive and Respiratory Syndrome Virus NSP2 Protein
Liu, B., Luo, L., Shi, Z., Ju, H., Yu, L., Li, G., & Cui, J. (2023) · Viruses · doi:10.3390/v15122310 · Cited by 34
Sorafenib resistance and therapeutic strategies in hepatocellular carcinoma
Zhang, W., Hong, X., Xiao, Y., Wang, H., & Zeng, X. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189310 · Cited by 34
Genetics and Pharmacology of Longevity
Castillo-Quan, J. I., Kinghorn, K. J., & Bjedov, I. (2015) · Advances in genetics · doi:10.1016/bs.adgen.2015.06.002 · Cited by 37
Impaired rRNA synthesis triggers homeostatic responses in hippocampal neurons
Kiryk, A., Sowodniok, K., Kreiner, G., Parkitna, J. M. R., Soenmez, A., Górkiewicz, T., Bierhoff, H., Wawrzyniak, M., Janusz, A., Liss, B., et al. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00207 · Cited by 35
Dual Specificity Phosphatase 5, a Specific Negative Regulator of ERK Signaling, Is Induced by Serum Response Factor and Elk-1 Transcription Factor
Buffet, C., CATELLI, M. G., Perlemoine, K., Bricaire, L., Garcia, C., Dierick-Gallet, A., Rodriguez, S., Cormier, F., & Groussin, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145484 · Cited by 35
Promising new strategies for hepatocellular carcinoma
Nakamoto, Y. (2016) · Hepatology Research · doi:10.1111/hepr.12795 · Cited by 34
Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles
Parvani, J. G., & Jackson, M. W. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0482 · Cited by 35
Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis
Reyes‐Gibby, C. C., Melkonian, S. C., Wang, J., Yu, R. K., Shelburne, S. A., Lu, C. S., Gunn, G. B., Chambers, M. S., Hanna, E. Y., Yeung, S. J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180396 · Cited by 34
Mechanisms of Matrix-Induced Chemoresistance of Breast Cancer Cells—Deciphering Novel Potential Targets for a Cell Sensitization
Jakubzig, B., Baltes, F., Henze, S., Schlesinger, M., & Bendas, G. (2018) · Cancers · doi:10.3390/cancers10120495 · Cited by 36
p90 ribosomal S6 kinase (RSK) phosphorylates myosin phosphatase and thereby controls edge dynamics during cell migration
Samson, S. C., Elliott, A., Mueller, B., Kim, Y., Carney, K. R., Bergman, J. P., Blenis, J., & Mendoza, M. C. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007431 · Cited by 32
Self-citation
Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma
Johnson, T. G., Schelch, K., Mehta, S. Y., Burgess, A., & Reid, G. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00221 · Cited by 34
Targeting NRAS-Mutant Cancers with the Selective STK19 Kinase Inhibitor Chelidonine
Qian, L. M., Chen, K., Wang, C., Chen, Z., Meng, Z., & Wang, P. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2604 · Cited by 34
Both Hypoxia-Inducible Factor 1 and MAPK Signaling Pathway Attenuate PI3K/AKT via Suppression of Reactive Oxygen Species in Human Pluripotent Stem Cells
Fojtík, P., Beckerová, D., Holomková, K., Šenfluk, M., & Rotrekl, V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.607444 · Cited by 35
The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance
Cronin, R., Brooke, G. N., & Prischi, F. (2021) · Oncogene · doi:10.1038/s41388-021-01810-9 · Cited by 33
m6A in the Signal Transduction Network
Jang, K.-H., Heras, C. R., & Lee, G. (2022) · Molecules and Cells · doi:10.14348/molcells.2022.0017 · Cited by 34
Will Kinase Inhibitors Make it as Glioblastoma Drugs?
Mellinghoff, I. K., Schultz, N. D., Mischel, P. S., & Cloughesy, T. F. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_178 · Cited by 36
Membrane localization of acetylated CNK1 mediates a positive feedback on RAF/ERK signaling
Fischer, A., Mühlhäuser, W. W. D., Warscheid, B., & Radziwill, G. (2017) · Science Advances · doi:10.1126/sciadv.1700475 · Cited by 34
AKT1 interacts with DHX9 to Mitigate R Loop–Induced Replication Stress in Ovarian Cancer
Huang, T., Chiang, C.-Y., Nair, J. R., Wilson, K. M., Cheng, K. C.-C., & Lee, J. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-1908 · Cited by 33
Common cancer-associated PIK3CA activating mutations rarely occur in Langerhans cell histiocytosis
Héritier, S., Saffroy, R., Radosevic‐Robin, N., Pothin, Y., Pacquement, H., Peuchmaur, M. M., Lemoine, A., Haroche, J., Donadieu, J., & Emile, J. (2015) · Blood · doi:10.1182/blood-2015-01-625491 · Cited by 33
Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1
Kim, E. J., Wang, Y., Kim, S. J., Bornhorst, M., Jecrois, E. S., Anthony, T. E., Wang, C., Li, Y. E., Guan, J., Murphy, G. G., et al. (2014) · eLife · doi:10.7554/elife.05151 · Cited by 34
β2-AR blockade potentiates MEK1/2 inhibitor effect on HNSCC by regulating the Nrf2-mediated defense mechanism
Mele, L. L., Vecchio, V. D., Marampon, F., Regad, T., Wagner, S., Mosca, L., Bimonte, S., Giudice, A., Liccardo, D., Prisco, C., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03056-x · Cited by 34
A proteome signature for acute incisional pain in dorsal root ganglia of mice
Pogatzki-Zahn, E. M., Gómez‐Varela, D., Erdmann, G., Kaschube, K., Segelcke, D., & Schmidt, M. (2021) · Pain · doi:10.1097/j.pain.0000000000002207 · Cited by 33
CD4+ T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8+ T-cell Targeting of HER2/ neu –Expressing Cancers
Datta, J., Xu, S., Rosemblit, C., Smith, J. B., Cintolo, J. A., Powell, D. J., & Czerniecki, B. J. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0208 · Cited by 33
Spatially resolved phosphoproteomics reveals fibroblast growth factor receptor recycling-driven regulation of autophagy and survival
Watson, J., Ferguson, H. R., Brady, R. M., Ferguson, J., Fullwood, P., Mo, H., Bexley, K., Knight, D., Howell, G. J., Schwartz, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34298-2 · Cited by 33
Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells
Du, W., Pang, C., Xue, Y., Zhang, Q., & Wei, X. (2015) · Oncology Letters · doi:10.3892/ol.2015.3699 · Cited by 32
Regulation of Interferon-Dependent mRNA Translation of Target Genes
Kroczyńska, B., Mehrotra, S., Arslan, A. D., Kaur, S., & Platanias, L. C. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0148 · Cited by 33
Connecting the dots: Overlaps between autism and cancer suggest possible common mechanisms regarding signaling pathways related to metabolic alterations
Wen, Y., & Herbert, M. R. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.05.004 · Cited by 33
Bidirectional manipulation of mTOR signaling disrupts socially mediated vocal learning in juvenile songbirds
Ahmadiantehrani, S., & London, S. E. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701829114 · Cited by 31
The functional significance of 14-3-3 proteins in cancer: focus on lung cancer
Khorrami, A., Bagheri, M. S., Tavallaei, M., & Gharechahi, J. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0032 · Cited by 32
Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODC
Kim, D. J., Lee, M., Liu, K., Lim, D. Y., Roh, E., Chen, H., Kim, S.-H., Shim, J., Kim, M. O., Li, W., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx082 · Cited by 32
Magnolin targeting of ERK1/2 inhibits cell proliferation and colony growth by induction of cellular senescence in ovarian cancer cells
Song, J., Lee, C., An, H., Yoo, S., Kang, H. C., Lee, J. Y., Kim, K. D., Kim, D. J., Lee, H. S., & Cho, Y. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22909 · Cited by 30
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
Ruicci, K. M., Plantinga, P., Pinto, N. C., Khan, M. I., Stecho, W., Dhaliwal, S. S., Yoo, J., Fung, K., MacNeil, S. D., Mymryk, J. S., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12558 · Cited by 32

Authors: Mendoza, M. C., Er, E. E., & Blenis, J.
Affiliations: Harvard University (US)
Corresponding author: Blenis, John
ORCID: Mendoza, Michelle C.
Er, E. Emrah
Blenis, John
Venue: Trends in Biochemical Sciences
Publisher: Elsevier BV
Published: 2011-06
Volume: 36
Issue: 6
Pages: 320-328
ISSN: 0968-0004 (ISSN-L)
DOI: 10.1016/j.tibs.2011.03.006
PMC: PMC3112285
OpenAlex: W1998203489
Cited by: 1,817
References: 103
Citations by year: 2026: 112 · 2025: 96 · 2024: 122 · 2023: 133 · 2022: 127 · 2021: 163 · 2020: 166 · 2019: 164 · 2018: 144 · 2017: 158 · 2016: 123 · 2015: 100 · 2014: 92 · 2013: 55 · 2012: 49
FWCI: 5.82
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Biochemical Sciences (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: LAM Foundation
Susan G. Komen
National Cancer Institute (R37CA046595)
National Institute of General Medical Sciences (R01GM051405)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: Ras/ERK signaling pathway, signaling crosstalk, cell survival, cell proliferation, cell differentiation, cellular metabolism, cell motility, proto-oncogenes, cancer therapeutics
MeSH terms: Humans, Signal Transduction, ras Proteins, Extracellular Signal-Regulated MAP Kinases, Phosphatidylinositol 3-Kinase, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks